SOAT1 and rheumatoid arthritis: Numerous experiments have shown the JAK-STAT pathway to be abnormally activated in rheumatoid arthritis (RA), Parkinson’s disease, multiple sclerosis, inflammatory bowel disease, sepsis, and development of tumors (Westhovens et al., 2017).